It does not reduce hydrogen sulfide production, but it can reduce the bloating and pressure that accompany sulfur burps
Abstract BACKGROUND: GLP-1 (glucagon-like peptide-1) receptor agonists (GLP-1RAs), initially developed for glycemic control in type 2 diabetes, have shown cardiometabolic benefits including weight loss, improved endothelial function, and reduced inflammation
Body Weight Considerations Peptides are often dosed based on body weight, typically in micrograms per kilogram
It wasnt about looking great, honestly I always felt pretty confident, it was about my quality of life
Often yes when prescribed for type 2 diabetes the medical necessity is built into the FDA label and a prescription alone is usually sufficient documentation
The dose escalation in days 16-30 is designed to reinforce the signaling pathways activated in Phase 1